Fulgent Genetics Inc - Company Profile

Powered by

All the data and insights you need on Fulgent Genetics Inc in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Fulgent Genetics Inc Strategy Report

  • Understand Fulgent Genetics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Fulgent Genetics Inc: Overview

Select Item

Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians. The company offers a range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. Its major offerings include genes and panels, known mutation, genomic testing, hereditary cancer, carrier screening, tumor profiling, newborn genetics and covid-19 testing. It offers genetic tests for cardiovascular and pediatric diseases, neurological disorders, cancers, and primarily serves medical institutions, hospitals in the US, Canada, and other countries. Fulgent is headquartered in Temple City, California, the US.

 Gain a 360-degree view of Fulgent Genetics Inc and make more informed decisions for your business Gain a 360-degree view of Fulgent Genetics Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 4399 Santa Anita Ave, El Monte, California, 91731
Website www.fulgentgenetics.com
Telephone 1 626 3500537
No of Employees 1,184
Industry Medical Equipment
Ticker Symbol & Exchange FLGT (NASD)
Revenue (2022) $289.2M -53.3% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -217% (2022 vs 2021)
Market Cap* $619.5M
Net Profit Margin (2022) XYZ -350.5% (2022 vs 2021)
* As of and is in US$
View Fulgent Genetics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Fulgent Genetics Inc premium industry data and analytics

2

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Products and Services

Products Services
Genes and Panels Sequencing Services
Known Mutation Lab services
Genomic Testing
XYZ
XYZ
XYZ
Understand Fulgent Genetics Inc portfolio and identify potential areas for collaboration Understand Fulgent Genetics Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In April, the company entered into an agreement with Mission Bio to offer single-cell multi-omics on the Tapestri Platform on its fully customizable menu of services.
2023 New Products/Services In February, the company announced the availability of new Beacon787 expanded carrier screening panel.
2022 Acquisitions/Mergers/Takeovers In November, the company completed the acquisition of Fulgent Pharma Holdings, Inc.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Fulgent Genetics Inc Laboratory Corp of America Holdings Natera Inc Myriad Genetics Inc InVitae Corp
Headquarters United States of America United States of America United States of America United States of America United States of America
City El Monte Burlington Austin Salt Lake City San Francisco
State/Province California North Carolina Texas Utah California
No. of Employees 1,184 67,000 3,282 2,700 1,700
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ming Hsieh Chief Executive Officer; President; Chairman Executive Board 2016 67
Paul Kim Chief Financial Officer Senior Management 2016 55
James Xie President; Chief Operating Officer Senior Management 2022 57
Dr. Lawrence Weiss, M.D. Chief Medical Officer Senior Management 2021 -
Hanlin Gao, M.D., Ph.D. Chief Scientific Officer; Lab Director Senior Management 2016 56
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Fulgent Genetics Inc key executives to enhance your sales strategy Gain insight into Fulgent Genetics Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward